Abstract
Hepatosplenic T-cell lymphoma is a rare histologic type of peripheral T-cell lymphoma, which is characterized clinically by predominant involvement of the liver and spleen, with little or no adenopathy, and an often aggressive course. We experienced a case of a 44-year-old female who was diagnosed with hepatosplenic γδ T-cell lymphoma with bone marrow involvement. The patient was treated with multi-agent chemotherapy with Bortezomib plus CHOP (cyclophosphamide, vincristine, prednisone, doxorubicin), Alemtuzumab plus DHAP (dexamethasone, cisplatin, cytarabine), and IMVP-16 (Ifosfamide, MTX, etoposide); however, she failed to achieve partial remission. After salvage chemotherapy (GemOx: Gembicine, oxaliplatin, dexamethasone), she underwent allogeneic stem cell transplantation from an HLA sibling donor with one mismatch. The patient is currently living and has remained in complete remission for 6 months since transplantation.
References
1. Harris NL, Jaffe ES, Stein H, et al. A revised european-american classification of lymphoid neoplasms. Blood. 1994; 84:1361–92.
2. Harris NL, Jaffe ES, Diebold J, et al. The world health organization classification of neoplastic diseases of the haematopoieticand lymphoid tissues: report of the clinical advisory committee meeting, air-lie house, virginia, November 1997. Histopathology. 2000; 36:69–86.
3. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gamma delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003; 102:4261–9.
4. Weidmann E, Hinz T, Klein S, et al. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features. Haematologica. 2000; 85:1024–31.
5. He S, Roberts A, Ritchie D, Grigg A. Graft-versus-lymphoma effect in progressive hepatosplenic gam-ma/delta T-cell lymphoma. Leuk Lymphoma. 2007; 48:1448–50.
6. Schafe E, Chen A, Arceci RJ. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation and early hematopoietic stem cell transplant. Pediatr Blood Cancer. 2009; 53:1127–9.
7. Konuma T, Doi J, Takahashi S, et al. Allogeneic stem cell transplantation for hepatosplenic gammadelta T cell lymphoma. Leuk Lymphoma. 2007; 48:630–2.
8. Falchook GS, Vega F, Dang NH, et al. Hepatosplenic gammadelta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol. 2009; 20:1080–5.
9. Park IG, Suh CW, Hur JR, et al. A case of a young woman with hepatosplenic gamma delta T-cell lymphoma. Cancer Res Treat. 2001; 33:264–8.
10. Lee SK, Woo HY, Park Q, Kim SH, Lee HG, Ko YH. A case of bone marrow involvement hepatosplenic γδ T-cell lymphoma. Korean J Hematol. 2002; 37:134–7.
11. Lee YS, Kim HJ, Park SH, et al. A case of hepatosplenic T-cell lymphoma mimicking a hemochromatosis. Korean J Med. 2006; 70:151–5.
12. Coventry S, Punnett HH, Tomczak EZ, et al. Consistency of isochromosome 7q and trisomy 8 in hepatosplenic gammadelta T-cell lymphoma: detection by fluorescence in situ hybridization of a splenic touch-preparation from a pediatric patient. Pediatr Dev Pathol. 1999; 2:478–83.